EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci – INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

por prodriguez | Ene 1, 2023 | Publicaciones - DE-02

Hidalgo-Tenorio, C; Sadyrbaeva-Dolgova, S; Enríquez-Gómez, A; Muñoz, P; Plata-Ciezar, A; Miró, JM; Alarcón, A; Martínez-Marcos, FJ; Loeches, B; Escrihuela-Vidal, F; Vinuesa, D; Herrero, C; Boix-Palop, L; Arenas, MD; Vázquez, EG; de las Revillas, FA – 2023...

Evaluation of three commercial methods of susceptibility testing for ceftolozane/tazobactam against carbapenem-resistant Pseudomonas aeruginosa – ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

por prodriguez | Ene 1, 2023 | Publicaciones - DE-02

López-Cerero, L; Ballesta, S; López, CE; Sánchez-Yebra, W; Rojo-Martin, MD; Pascual, A – 2023 – 10.1016/j.eimc.2022.09.009

Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci. – CLINICAL INFECTIOUS DISEASES

por prodriguez | Ene 1, 2023 | Publicaciones - DE-02

Escrihuela-Vidal, F; Berbel, D; Fernandez-Hidalgo, N; Escola-Verge, L; Munoz, P; Olmedo, M; Goenaga, MA; Goikoetxea, J; Farinas, MC; De Alarcon, A; Miro, JM; Ojeda, G; Plata, A; Cuervo, G; Carratala, J; GAMES Investigators – 2023 –...

Non-nosocomial Healthcare-Associated Infective Endocarditis: A Distinct Entity? Data From the GAMES Series (2008-2021) – OPEN FORUM INFECTIOUS DISEASES

por prodriguez | Ene 1, 2023 | Publicaciones - DE-02

Alonso-Menchen, D; Bouza, E; Valerio, M; de Alarcon, A; Gutierrez-Carretero, E; Miro, JM; Goenaga-Sanchez, MA; Plata-Ciezar, A; Gonzalez-Rico, C; Lopez-Cortes, LE; Esteban, MAR; Martinez-Marcos, FJ; Munoz, P – 2023 – 10.1093/ofid/ofad393

Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control- control study (EURECA) – ECLINICALMEDICINE

por prodriguez | Ene 1, 2023 | Publicaciones - DE-02

Perez-Galera, S; Bravo-Ferrer, JM; Paniagua, M; Kostyanev, T; de Kraker, MEA; Feifel, J; Sojo-Dorado, J; Schotsman, J; Canton, R; Daikos, GL; Carevic, B; Dragovac, G; Tan, LK; Raka, L; Hristea, A; Viale, P; Akova, M; Reguera, JM; de Santis, LV; Torre-Cisneros, J;...

Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial – OPEN FORUM INFECTIOUS DISEASES

por prodriguez | Ene 1, 2023 | Publicaciones - DE-02

Trigo-Rodriguez, M; Carcel, S; Navas, A; Espindola-Gomez, R; Garrido-Gracia, JC; Moreno, MAE; Leon-Lopez, R; Perez-Crespo, PMM; Alonso, EA; Vinuesa, D; Romero-Palacios, A; Perez-Camacho, I; Gutierrez-Gutierrez, B; Martinez-Marcos, FJ; Fernandez-Roldan, C; Leon, E;...